Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Thrombin-binding anticoagulant disclosed by Japanese scientists

Jan. 10, 1997

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Jan. 9, 1997

Potential HIV-1 therapy disclosed by Houghten

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

Galderma develops novel compounds active on cell differentiation and proliferation

Jan. 9, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...